Vimarsana
Biggest News Aggregation in the World

Page 30 - Electron Microscopy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Electron Microscopy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Electron Microscopy Today - Breaking & Trending Today

Cross Company Testing Group Adds a Number of New Capabilities - Vimarsana News

Cross Company Testing Group Adds a Number of New Capabilities

Greenville, SC (PRWEB) November 18, 2022 -- Cross Company-Testing Division recently added a number of new capabilities as well as expanded capacity in the

Source: prweb.com
Previously unseen processes reveal path to better rechargeable battery performance - Vimarsana News

Previously unseen processes reveal path to better rechargeable battery performance

To design better rechargeable ion batteries, engineers and chemists from the University of Illinois Urbana-Champaign collaborated to combine a powerful new electron microscopy technique and data m ...

Structural Insights Help Us Understand Influenza's Replication - Vimarsana News

Structural Insights Help Us Understand Influenza's Replication

Researchers have solved the structure of the influenza virus' replication machinery, giving structural insights into new potential drug targets and how the virus adapts to different hosts.

FAU Receives $599,503 DOD Grant for Powerful Tool with Nanoscale Imaging Capabilities - Vimarsana News

FAU Receives $599,503 DOD Grant for Powerful Tool with Nanoscale Imaging Capabilities

Florida Atlantic University has received a $599,503 grant from the United States Department of Defense for a powerful high resolution imaging technique that can reveal nanoscale structures.

SpyCatcher-SpyTag technology used to develop recombinant protein-based intranasal vaccine against SARS-CoV-2 - Vimarsana News

SpyCatcher-SpyTag technology used to develop recombinant protein-based intranasal vaccine against SARS-CoV-2

The findings of a new study showed that the intranasal SpyCage vaccine platform can be protective against SARS-CoV-2 and may prove to be a versatile and adaptable modality for the formulation of intranasal vaccines that target respiratory pathogens.